Ask a Question
  • Women's Health
  • Oncology
  • Cardio Renal
  • Ophthalmology

Medical Literature Recent Updates

FIGARO-DKD study infographic results
The infographic highlights the Study Results for FIGARO-DKD.
Guidance from the Scientific Society of CKD in T2D
PDF / 45 pages / 3050KB

FIDELITY

FIDELITY GLP-1RA
This slide deck illustrates the role of Finerenone in patients across the spectrum of chronic kidney disease (CKD) an...
FIDELITY Resources
This slide deck presents the FIDELITY pooled-analysis and key associated subanalyses that investigates the effectiven...

CONFIDENCE

CONFIDENCE publication
The CONFIDENCE trial, is a multicenter, randomized, double-blind, double dummy, three-armed parallel group study. Thi...
CONFIDENCE Study
The primary objective of the CONFIDENCE trial was to assess the reduction of urine albumin-creatinine ratio (UACR) us...
CONFIDENCE core deck
This slide deck presents the CONFIDENCE study, a randomized controlled trial that investigates the effectiveness of F...
FOUNTAIN (RWE)
The Finerenone Multi-database Network for Data Generation (FOUNTAIN) aims to provide comprehensive evidence regarding...

Finerenone: Practical Considerations

Product Monograph - Finerenone
Find the most up-to-date version of the product monograph for Kerendia (Finerenone) tablets.
Practical use of Finerenone
This slide deck highlights the practical use of Finerenone.

CKD management in T2D: guidelines and insights

Case studies in the management of T2D and CKD
The slide deck highlights patient case studies in the management of type 2 diabetes (T2D) and chronic kidney disease ...
Guidance from the Scientific Society of CKD in T2D
This slidedeck presents the guidance from scientific societies for identifying chronic kidney disease (CKD) in patien...
The 2025 Diabetes Canada guidelines on CKD in diabetes
This slide deck summarizes the Diabetes Canada 2025 Chronic Kidney Disease (CKD) Clinical Practice Guidelines update,...
ADA KDIGO consensus statement
This slide deck covers the 2022 consensus statement from the ADA/KDIGO guidelines on the management of diabetes and c...

FIGARO

FIGARO-DKD study
FIGARO-DKD (Diabetic Kidney Disease), a phase 3 clinical trial focused to assess the cardiovascular outcomes of Finer...
FIGARO-DKD study infographic results
The infographic highlights the Study Results for FIGARO-DKD.
FIGARO-BM study
The slide deck illustrates the findings of FIGARO-BM, a biomarker study of FIGARO-DKD, which reveal new insights into...

Videos

Cardiovascular disease ERA 2024 pipeline video
This video highlights Bayer's continued commitment to cardiovascular disease to bring innovative treatments to patients.
FIDELITY results
This short video highlights the results of FIDELITY, a pre-specified meta-analysis combining two studies, FIGARO-DKD ...
Hypothesized mode of action and pharmacology of Finerenon...
This video highlights the hypothesized mode of action and pharmacology of Finerenone based on preclinical animal modes.

Pipeline

FIND-CKD
The slide deck reviews the trial for Finerenone in non-diabetic chronic kidney disease (FIND-CKD).
FINEOVATE: FINERENONE life cycle management
The slide deck outlines the FINEOVATE program, which is investigating the efficacy and safety of FINERENONE in patien...
The FIONA study
The slide deck reviews the FIONA study, which investigates the efficacy, safety, and pharmacokinetics/ pharmacodynami...